1. Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
   Yunliang Tang et al, 2021, Aging CrossRef
2. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
   Alexander W. Pohlman et al, 2022, Oncotarget CrossRef
3. Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma
   Jun Chen et al, 2022, Front. Oncol. CrossRef
4. Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma
   Zhenglan Zhong et al, 2022, Journal of Healthcare Engineering CrossRef
5. Nitrogen Metabolism Disorder Accelerates Occurrence and Development of Lung Adenocarcinoma: A Bioinformatic Analysis and In Vitro Experiments
   Zexin Zhang et al, 2022, Front. Oncol. CrossRef
6. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer
   Xiongye Xu et al, 2022, CPD CrossRef
7. Insulin-like growth factor binding protein 5: Diverse roles in cancer.
   Jennifer A Waters et al, 2022, Front Oncol CrossRef
8. Varying severity COVID-19 effects on the blood indicators of insulin-like growth factors family in patients with nonsmall cell lung cancer
   O. I. Kit et al, 2023, jour CrossRef
9. Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation
   Chaowang Zhou et al, 2025, Discov Onc CrossRef